ADIPOQ and type 2 diabetes mellitus: Most interestingly and similar to adiponectin, systemic CTRP-3 levels have repeatedly been described to be lower in subjects suffering from obesity and/or type 2 diabetes mellitus when compared to normal-weight and normo-glycemic individuals [13,14,15].